Last updated: 13 October 2026 | Author: Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience A diagnosis of retinitis pigmentosa (RP) is hard to hear, and many families quickly search for stem cell treatment for retinitis pigmentosa. This guide explains what RP
Last updated: 9 October 2026 | Author: Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Retinal dystrophy disease treatment in India is a topic many families search for after a diagnosis of an inherited retinal condition. The honest starting point is this: retinal
Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Diabetic retinopathy (DR) is one of the leading causes of blindness among working-age adults, caused by long-term damage to the blood vessels in the retina from high blood sugar. As
Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Age-related macular degeneration (AMD) is the leading cause of severe vision loss in people over 55 in the developed world, gradually affecting central vision needed for reading, driving, and recognizing
Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Eye stem cell treatment itself is usually a single, minimally invasive procedure — but what happens before and after it often matters just as much for long-term outcomes. For patients
Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Glaucoma is often called the “silent thief of sight” because it typically progresses without noticeable symptoms until significant, irreversible vision loss has already occurred. As one of the leading causes
Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience If you’re considering stem cell treatment for an eye condition, the clinic you choose matters just as much as the treatment itself. With regenerative medicine growing rapidly, patients now face
Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Unlike many stem cell treatments still confined to research trials, corneal stem cell therapy for limbal stem cell deficiency (LSCD) is one of the few genuinely established, evidence-backed regenerative treatments
Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Diabetic retinopathy is one of the most common complications of long-standing diabetes and remains a leading cause of vision loss among working-age adults worldwide. As blood sugar levels stay elevated
Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience Age-related macular degeneration (AMD) is the leading cause of vision loss in older adults in many parts of the world. It affects the macula — the central part of the

